Achieve Life Sciences (ACHV) Profit After Tax (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Profit After Tax came in at -$10.2 million in Q1 2026, up 20.88% YoY from -$8.4 million in Q1 2025, and up 30.36% on a QoQ basis from -$14.6 million in Q4 2025.
Achieve Life Sciences (ACHV) Profit After Tax (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Profit After Tax data on file, last reported at -$10.2 million in Q1 2026.
- Quarterly Profit After Tax rose 20.88% year-over-year to -$10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.9 million (down 12.5% YoY) and the FY2025 annual result came in at -$54.6 million, down 37.09% from the prior year.
- Profit After Tax improved to -$10.2 million in Q1 2026, from -$14.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$5.5 million in Q4 2023 to a low of -$14.6 million in Q4 2025.
- A 5-year average of -$10.4 million and a median of -$10.5 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax soared 51.25% — and 2024, when it tumbled 125.11%.
- Tracing ACHV's Profit After Tax over 5 years: stood at -$11.2 million in 2022, then soared by 51.25% to -$5.5 million in 2023, then tumbled by 125.11% to -$12.3 million in 2024, then declined by 18.44% to -$14.6 million in 2025, then soared by 30.36% to -$10.2 million in 2026.
- The last three Profit After Tax figures came in at -$10.2 million (Q1 2026), -$14.6 million (Q4 2025), and -$14.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | -74.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.86 Mn |
| Mar 31, 2026 | -10.17 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -14.44 Mn |
| Jun 30, 2025 | -12.72 Mn |
| Mar 31, 2025 | -12.85 Mn |
| Dec 31, 2024 | -12.33 Mn |
| Sep 30, 2024 | -12.51 Mn |
| Jun 30, 2024 | -8.46 Mn |
| Mar 31, 2024 | -6.49 Mn |
| Dec 31, 2023 | -5.48 Mn |
| Sep 30, 2023 | -7.11 Mn |
| Jun 30, 2023 | -8.24 Mn |
| Mar 31, 2023 | -8.99 Mn |
| Dec 31, 2022 | -11.23 Mn |
| Sep 30, 2022 | -13.08 Mn |
| Jun 30, 2022 | -10.47 Mn |
| Mar 31, 2022 | -7.57 Mn |
| Dec 31, 2021 | -7.15 Mn |
| Sep 30, 2021 | -6.69 Mn |